Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A McCulloch

Showing results (631-640 of 635) with videos related to

Pageof 64
Sort By:
You have reached the last page of results.This site can display upto 635 results.
Science (New York, N.Y.)|February 5, 2021
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patientsDiwakar Davar, Amiran K Dzutsev, John A McCulloch, et al.
Cell|July 10, 2025
Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacyCatherine M Phelps, Nathaniel B Willis, Tingting Duan, et al.
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Nature Communications|February 21, 2024
Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndromeBrian Walitt, Komudi Singh, Samuel R LaMunion, et al.
Science (New York, N.Y.)|December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Pageof 64

Showing results (631-640 of 635) with videos related to

Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 635 results.
Science (New York, N.Y.)|February 5, 2021
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patientsDiwakar Davar, Amiran K Dzutsev, John A McCulloch, et al.
Cell|July 10, 2025
Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacyCatherine M Phelps, Nathaniel B Willis, Tingting Duan, et al.
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Nature Communications|February 21, 2024
Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndromeBrian Walitt, Komudi Singh, Samuel R LaMunion, et al.
Science (New York, N.Y.)|December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Pageof 64